Nom du produit:4-((4-(4-(1H-1,2,3-Triazol-1-yl)butyl)phenoxy)methyl)-2-(4-(trifluoromethyl)styryl)oxazole hydrochloride
IUPAC Name:1-{4-[4-({2-[(1E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl}methoxy)phenyl]butyl}-1H-1,2,3-triazole hydrochloride
- CAS:391202-06-5
- Formule moléculaire:C25H24ClF3N4O2
- Pureté:97%
- Numéro de catalogue:CM519479
- Poids moléculaire:504.94
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:391202-06-5
- Formule moléculaire:C25H24ClF3N4O2
- Point de fusion:-
- Code SMILES:FC(F)(F)C(C=C1)=CC=C1/C=C/C2=NC(COC3=CC=C(CCCCN4C=CN=N4)C=C3)=CO2.Cl
- Densité:
- Numéro de catalogue:CM519479
- Poids moléculaire:504.94
- Point d'ébullition:
- N° Mdl:MFCD28968059
- Stockage:
Category Infos
- Oxazoles
- Oxazoles are heterocyclic aromatic compounds containing one oxygen atom and one nitrogen atom, separated by a carbon atom. The presence of two heteroatoms (oxygen and nitrogen) provides possible interactions (hydrogen, hydrophobic, van der Waals or dipole bonds) with a wide range of receptors and enzymes. Oxazole rings are valuable heterocyclic scaffolds for the design of novel therapeutics with anticancer, antiviral, antibacterial, anti-inflammatory, neuroprotective, antidiabetic, and antidepressant properties due to their wide range of targets and biological activities.